NasdaqCM:VMD

Stock Analysis Report

Executive Summary

Viemed Healthcare, Inc., through its subsidiaries, provides in-home health care solutions in the United States.

Snowflake

Fundamentals

Solid track record with high growth potential.

Share Price & News

How has Viemed Healthcare's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

5.8%

NasdaqCM:VMD

0.8%

US Healthcare

1.3%

US Market


1 Year Return

41.1%

NasdaqCM:VMD

-8.2%

US Healthcare

2.0%

US Market

VMD outperformed the Healthcare industry which returned -8.2% over the past year.

VMD outperformed the Market in United States of America which returned 1.7% over the past year.


Share holder returns

VMDIndustryMarket
7 Day5.8%0.8%1.3%
30 Day-2.3%-1.5%3.9%
90 Day-10.7%-0.5%3.4%
1 Year41.1%41.1%-6.8%-8.2%4.2%2.0%
3 Yearn/a30.2%24.9%47.2%37.6%
5 Yearn/a63.6%53.9%60.5%42.9%

Price Volatility Vs. Market

How volatile is Viemed Healthcare's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Viemed Healthcare undervalued based on future cash flows and its price relative to the stock market?

31%

Discount to future cash flow value


Intrinsic Value Based on Future Cash Flows

Viemed Healthcare's share price is below the future cash flow value, and at a moderate discount (> 20%).

Viemed Healthcare's share price is below the future cash flow value, but not at a substantial discount (< 40%).


Price Based on Earnings

Viemed Healthcare is overvalued based on earnings compared to the US Healthcare industry average.

Viemed Healthcare is overvalued based on earnings compared to the United States of America market.


Price Based on Expected Growth

Viemed Healthcare is good value based on expected growth next year.


Price Based on Value of Assets

Viemed Healthcare is overvalued based on assets compared to the US Healthcare industry average.


Next Steps

Future Growth

How is Viemed Healthcare expected to perform in the next 1 to 3 years based on estimates from 3 analysts?

44.3%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Viemed Healthcare's revenue is expected to grow significantly at over 20% yearly.

Viemed Healthcare's earnings are expected to grow significantly at over 20% yearly.

Viemed Healthcare's revenue growth is expected to exceed the United States of America market average.

Viemed Healthcare's earnings growth is expected to exceed the United States of America market average.

Viemed Healthcare's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if Viemed Healthcare will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has Viemed Healthcare performed over the past 5 years?

3.1%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Viemed Healthcare's year on year earnings growth rate has been positive over the past 5 years.

Viemed Healthcare's 1-year earnings growth exceeds its 5-year average (8.6% vs 3.1%)

Viemed Healthcare's earnings growth has exceeded the US Healthcare industry average in the past year (8.6% vs 5.6%).


Return on Equity

Viemed Healthcare has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).


Return on Assets

Viemed Healthcare used its assets more efficiently than the US Healthcare industry average last year based on Return on Assets.


Return on Capital Employed

Viemed Healthcare's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).


Next Steps

Financial Health

How is Viemed Healthcare's financial position?


Financial Position Analysis

Viemed Healthcare is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Viemed Healthcare's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Viemed Healthcare's level of debt (12.6%) compared to net worth is satisfactory (less than 40%).

Unable to establish if Viemed Healthcare's debt level has increased without past 5-year debt data.

Debt is well covered by operating cash flow (391.6%, greater than 20% of total debt).

Interest payments on debt are well covered by earnings (EBIT is 93x coverage).


Balance Sheet

High level of physical assets or inventory.

Debt is covered by short term assets, assets are 5.1x debt.


Next Steps

Dividend

What is Viemed Healthcare's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Viemed Healthcare's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Viemed Healthcare's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Viemed Healthcare has not reported any payouts.

Unable to verify if Viemed Healthcare's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Viemed Healthcare has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Viemed Healthcare's salary, the management and board of directors tenure and is there insider trading?

1.8yrs

Average management tenure


CEO

Casey Hoyt (42yo)

1.8yrs

Tenure

US$1,828,844

Compensation

Mr. Casey Hoyt has been Director of Viemed Healthcare, Inc. since December 14, 2016 and serves as Chief Executive Officer. Mr. Hoyt served as Chief Executive Officer of Patient Home Monitoring Corp. from  ...


CEO Compensation Analysis

Casey's remuneration is higher than average for companies of similar size in United States of America.

Casey's compensation has increased by more than 20% in the past year whilst earnings grew less than 20%.


Management Age and Tenure

1.8yrs

Average Tenure

44yo

Average Age

The average tenure for the Viemed Healthcare management team is less than 2 years, this suggests a new team.


Board Age and Tenure

1.8yrs

Average Tenure

53yo

Average Age

The average tenure for the Viemed Healthcare board of directors is less than 3 years, this suggests a new board.


Insider Trading

No 3 month open market individual insider trading information.


Recent Insider Transactions

SellUS$133,02709 Jan 19
Casey Hoyt
EntityIndividual
Role
Chief Executive Officer
CEO & Director
Shares32,625
Max PriceUS$4.08
SellUS$129,69609 Jan 19
Michael Moore
EntityIndividual
Role
President
President
Shares31,808
Max PriceUS$4.08
SellUS$50,86609 Jan 19
Trae Fitzgerald
EntityIndividual
Role
Chief Financial Officer
Chief Financial Officer
Shares12,475
Max PriceUS$4.08
SellUS$181,85909 Jan 19
W. Zehnder
EntityIndividual
Role
Member of the Board of Directors
COO & Director
Shares44,601
Max PriceUS$4.08
BuyUS$50,19320 Nov 18
Michael Moore
EntityIndividual
Role
President
President
Shares11,000
Max PriceUS$4.56
BuyUS$34,30020 Nov 18
Casey Hoyt
EntityIndividual
Role
Chief Executive Officer
CEO & Director
Shares10,000
Max PriceUS$3.43

Ownership Breakdown


Management Team

  • Robbie Grossman (45yo)

    Corporate Secretary

    • Tenure: 1.8yrs
  • Casey Hoyt (42yo)

    CEO & Director

    • Tenure: 1.8yrs
    • Compensation: US$1.83m
  • Michael Moore (41yo)

    President

    • Tenure: 1.8yrs
    • Compensation: US$1.70m
  • Brett Stoute

    Chief Compliance Officer

    • Tenure: 0yrs
  • W. Zehnder (44yo)

    COO & Director

    • Tenure: 1.8yrs
    • Compensation: US$1.66m
  • William Frazier (61yo)

    Chief Medical Officer & Director

    • Tenure: 1.8yrs
    • Compensation: US$421.34k
  • Trae Fitzgerald (31yo)

    Chief Financial Officer

    • Tenure: 1.8yrs
    • Compensation: US$593.33k
  • Kavish Shah

    Chief Information Officer

    • Tenure: 0yrs
  • Jerome Cambre (48yo)

    Vice President of Sales

    • Tenure: 1.5yrs

Board Members

  • Randy Dobbs (68yo)

    Chairman

    • Tenure: 1.8yrs
    • Compensation: US$213.08k
  • Nitin Kaushal (53yo)

    Director

    • Tenure: 1.8yrs
    • Compensation: US$213.08k
  • Casey Hoyt (42yo)

    CEO & Director

    • Tenure: 1.8yrs
    • Compensation: US$1.83m
  • W. Zehnder (44yo)

    COO & Director

    • Tenure: 1.8yrs
    • Compensation: US$1.66m
  • William Frazier (61yo)

    Chief Medical Officer & Director

    • Tenure: 1.8yrs
    • Compensation: US$421.34k
  • Tim Smokoff (54yo)

    Director

    • Tenure: 1.8yrs
    • Compensation: US$213.08k
  • Bruce Greenstein (51yo)

    Independent Director

    • Tenure: 1.2yrs
    • Compensation: US$112.50k

Company Information

Viemed Healthcare, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Viemed Healthcare, Inc.
  • Ticker: VMD
  • Exchange: NasdaqCM
  • Founded:
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: CA$340.377m
  • Listing Market Cap: CA$256.640m
  • Shares outstanding: 37.74m
  • Website: https://www.viemed.com

Number of Employees


Location

  • Viemed Healthcare, Inc.
  • 202 North Luke Street
  • Lafayette
  • Louisiana
  • 70506
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
VMDTSX (The Toronto Stock Exchange)YesCommon SharesCACADDec 2017
VMDNasdaqCM (Nasdaq Capital Market)YesCommon SharesUSUSDDec 2017

Biography

Viemed Healthcare, Inc., through its subsidiaries, provides in-home health care solutions in the United States. The company offers respiratory services and related equipment, including non-invasive ventila ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/16 00:34
End of Day Share Price2019/09/13 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.